Microba Life Sciences Limited Operating Income

Microba Life Sciences Limited (MAP.AX) currently reports a operating income of $-39M as of June 2026. That compares with $-47M in the prior-year period — up 16.8% year over year. Use the charts on this page to explore Microba Life Sciences Limited's operating income history and peer comparisons.

Microba Life Sciences Limited's operating income increased from $-47M to $-39M — a 16.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Microba Life Sciences Limited reported $-39M in operating income as of June 2026. That compares with $-47M in the prior-year period — up 16.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-39M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Microba Life Sciences Limited, and consider following MAP.AX for alerts when major investors trade the stock.